Related Experiment Video
Updated: Jul 5, 2026
09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Boosting controlled autoimmunity: a new therapeutic target for CNS disorders
Diana García del Barco1, Jorge Berlanga, Eduardo Penton
1Center for Genetic Engineering & Biotechnology, Avenue 31 e/158 & 190, PO Box 6162, Cubancan, Playa 10600, Havana City, Cuba. diana.garcia@cigb.edu.cu
Expert Review of Neurotherapeutics
|May 7, 2008
Summary
The central nervous system (CNS) uses a regulated immune surveillance system for protection and repair. Harnessing protective immunity in the CNS may offer new treatments for neurodegenerative and neuroinflammatory diseases.
Area of Science:
- Neuroimmunology
- Central Nervous System (CNS) Research
- Immune System Function
Background:
- The immune system is crucial for tissue protection, repair, and healing in most organs.
- The central nervous system (CNS), despite being immunologically privileged, undergoes a regulated form of immunosurveillance.
- This immunosurveillance in the CNS is gaining significant research interest.
Purpose of the Study:
- To explore the potential of leveraging innate protective immunity for CNS repair mechanisms.
- To understand the regulatory processes governing protective autoimmunity within the CNS.
- To identify novel therapeutic strategies for neuroinflammatory and neurodegenerative conditions.
Main Methods:
- Review of existing literature on CNS immunity and repair.
- Analysis of evidence for immune system involvement in CNS healing.
- Investigation of regulatory mechanisms of protective autoimmunity.
Main Results:
- Evolving evidence suggests CNS repair can be enhanced by innate protective immunity.
- Understanding CNS immune regulation is key to therapeutic development.
- Protective autoimmunity in the CNS is a focus for novel treatment strategies.
Conclusions:
- Exploiting innate protective immunity presents a promising avenue for CNS repair.
- Further understanding of CNS immune regulation can unlock new therapies.
- Targeting protective autoimmunity may lead to breakthroughs in treating neurodegenerative and neuroinflammatory diseases.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...